Skip to main content
Caplight Logo









OpenProtein.AI

OpenProtein.AI

Private
SingaporeHealthcare & Life Scienceshttps://openprotein.ai

Company Overview

OpenProtein.AI operates in Healthcare & Life Sciences and is based in Singapore. It was founded in 2021.

OpenProtein.AI is a biotechnology company that provides an AI-based, no-code platform for protein engineering, design, and analysis.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Low-Code/No-Code

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting, Usage-Based SaaS

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

OpenProtein.AI Comparables

Compare OpenProtein.AI with similar companies based on industry and business-model similarity.

OpenProtein.AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
310.ai
89%
Chan Zuckerberg Biohub
80%
Levitate
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

OpenProtein.AI Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for OpenProtein.AI. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Tristan Bepler

Co-Founder And CEO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors increased 63% MoM.

  • Jan 21, 2026

    Monthly visitors increased 55% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

OpenProtein.AI Filings

Explore SEC and related filing metadata, where available.

OpenProtein.AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about OpenProtein.AI's valuation, stock price, and market status.

Is OpenProtein.AI a public or private company?

OpenProtein.AI is a private company.

What is the current stock price of OpenProtein.AI?

OpenProtein.AI is a private company, so its shares have no public market price. Caplight tracks OpenProtein.AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OpenProtein.AI worth (valuation)?

Valuation information for OpenProtein.AI is not publicly available.

Can I buy OpenProtein.AI stock?

OpenProtein.AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OpenProtein.AI's last funding round?

Funding round information for OpenProtein.AI is not publicly available.

Who are the main investors in OpenProtein.AI?

Investor information for OpenProtein.AI is not publicly disclosed.

Will OpenProtein.AI IPO soon?

No public IPO plans have been announced for OpenProtein.AI.

How can I track OpenProtein.AI secondary market activity?

Caplight tracks bids, offers, and trades in OpenProtein.AI's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range9
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?